Health Outcomes in Autistic and Non-Autistic Adults with hEDS/HSD

Overview

This study investigates differences in health outcomes and experiences between autistic and non-autistic adults diagnosed with hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD). It highlights the overlap in symptomatology and the impact of autistic traits on physical and mental health in these populations.

Background

Hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS) are hereditary connective tissue disorders characterized by joint hypermobility and tissue fragility, with no current genetic test available. Diagnosis relies on clinical criteria including joint flexibility, systemic symptoms, family history, and exclusion of other disorders. Autism is a neurodevelopmental condition with elevated rates of physical and mental health comorbidities, and recent research indicates increased prevalence of hypermobility in autistic individuals. Both conditions share clinical heterogeneity, hereditary factors, and overlapping symptoms such as sensory processing differences and autonomic dysregulation. Understanding how autism and hypermobility intersect is critical to improving healthcare experiences and outcomes.

Data Highlights

The study utilized a quantitative cross-sectional survey of UK adults with hEDS/HSD, examining self-reported physical and mental health outcomes across groups defined by autism diagnosis and levels of autistic traits. Key measures included joint hypermobility assessment, systemic symptom reporting, and healthcare experience evaluations.

Key Findings

• Autistic adults with hEDS/HSD report distinct health experiences compared to non-autistic adults, including differences in symptom severity and healthcare satisfaction.
• Higher levels of autistic traits correlate with variations in physical and mental health outcomes among people with hEDS/HSD.
• There is significant overlap in sensory processing differences, autonomic dysfunction, and mental health challenges between autistic and hypermobile populations.
• Barriers to healthcare access for autistic individuals with hEDS/HSD include sensory sensitivities, communication differences, and lack of provider knowledge.
• Clinical tools like the Beighton score have limitations in sensitivity and may not fully capture joint hypermobility across diverse populations.

Clinical Implications

Clinicians should be aware of the high co-occurrence of autism and hypermobility disorders and consider the unique challenges faced by autistic patients in managing hEDS/HSD. Enhanced training for healthcare professionals on both autism and hypermobility is essential to improve diagnostic accuracy and patient-centered care. Tailored management strategies addressing sensory sensitivities and communication needs can facilitate better health outcomes.

Conclusion

This research underscores the complex interplay between autism and hypermobility disorders, revealing differences in health experiences and outcomes that necessitate integrated, informed clinical approaches. Recognizing and addressing these overlaps can improve care quality and patient satisfaction for this underserved population.

Related Resources & Content

1. Castori et al. 2017 -- Diagnostic criteria for hEDS
2. Baeza-Velasco et al. 2022 -- Autism and hypermobility link
3. Cederlöf et al. 2016 -- Prevalence of hEDS/HSD
4. Murray et al. 2021 -- Healthcare experiences in hEDS/HSD
5. Lai et al. 2014 -- Autism diagnostic criteria